Cefodizime stimulates subpopulations of cells mediating spontaneous or antibody-dependent cytotoxicity in patients with bacterial infections

Roitt, I. M., Brostoff, J., Male, D. K. Immunology. Gower Medical Publishing Ltd., London 1985.

Miyake, Y., Tomonage, M., Tokoh, T., Yamada, Y., Ishida, N., Hyodo, A., Inoue, M.: Mechanism of the excellentin vivo action of THR-221. In: Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York 1987, Abstract 670.

Kasai, K., Tsuji, A., Miyazaki, S., Goto, S., Fujimoto, K., Masuyoshi, S., Arai, S. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic. Jpn. J. Antibiot. 37 (1984) 1306–1312.

Miyake, Y., Tomonaga, M., Tokoh, T., Yamada, Y., Ishida, N., Hyodo, A. Therapeutic efficacy of cefodizime against experimental infections in immunosuppressed mice. Chemotherapy (Tokyo) 36 (S 5) (1988) 128–139.

Remington, J. Communication at the workshop “Antibiotics and the Immune System with Special Reference to Cefodizime,” Wiesbaden, December 20, 1984 (Sponsor: Hoechst AG).

Auer, I. O., Ziemer, E., Sommer, H. Immune status in Crohn's disease. V. Decreasedin vitro natural killer cell activity in peripheral blood. Clin. Exp. Immunol. 42 (1980) 41–46.

Hoechst AG Cefodizime documentation. Hoechst AG, Frankfurt 1991.

Tapazoglou, E., Prasad, A. S., Hill, G., Brewer, G. J., Kaplan, J. Decreased natural killer cell activity in zinc deficient subjects. J. Lab. Clin. Med. 105 (1985) 19–22.

Lowell, G. H., Smith, L. S., Artenstein, M. S., Nash, G. S., MacDermott, R. D. Antibody dependent cell mediated antibacterial activity of human mononuclear cells. J. Exp. Med. 150 (1979) 127–137.

Scott, R., Landazuri, M. E., Gardner, P. S., Owen, J. J. T. Human antibody dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytical virus. Clin. Exp. Immunol. 28 (1977) 19–26.

Van Der Straeten, M., Valcke, Y.: Lymphocyte subpopulations in patients with acute lower respiratory tract infections treated with cefodizime. In: Program and abstracts of the 17th International Congress of Chemotherapy, Berlin 1991, Abstract 815.

Vanholder, R., Van Landschoot, N., Dagrosa, E., Ringoir, S. Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure. Nephrol. Dial. Transplant. 2 (1988) 221–224.